Skip to content

Addiction: all studies

Page 310 of 857: studies 3,091 to 3,100 of 8,563, newest first. Back to the addiction overview

Research

Delay Coordinate Embedding as Neuronally Implemented Information Processing: The State Space Theory of Consciousness

Journal of Consciousness Studies February 1, 2025 V. O’Reilly-Shah

This paper introduces the state space theory of consciousness, positing that the cortex processes information through delay coordinate embedding operationalized by recurrent neural network engines. This leverages the power of Takens' theorem, giving rise to representations of reality as points within state space. Consciousness is posited to arise at the highest order engines amongst...

Muscarinic cannabinoid suppression of excitation, a novel form of coincidence detection.

Pharmacological Research February 1, 2025 Michaela Dvorakova, Ken Mackie, Alex Straiker 2 citations

Δ9-tetrahydrocannabinol (THC), the chief psychoactive ingredient of cannabis, acts in the brain primarily via cannabinoid CB1 receptors. These receptors are implicated in several forms of synaptic plasticity - depolarization-induced suppression of excitation (DSE), metabotropic suppression of excitation (MSE), long term depression (LTD) and activation-dependent desensitization. Cultured...

DOI: 10.1016/j.phrs.2025.107606 (opens in new tab) Full text (opens in new tab) Synaptic plasticity Autaptic hippocampal neurons Cb1 receptor M3/m5 muscarinic receptors

Prolonged incubation with Δ9-tetrahydrocannabinol but not with cannabidiol induces synaptic alterations and mitochondrial impairment in immature and mature rat organotypic hippocampal slices.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie February 1, 2025 Costanza Mazzantini, Lorenzo Curti, Daniele Lana et al.

Cannabis derivatives are among the most widely used psychoactive substances in the world, which leads to growing medical concerns regarding its chronic use and abuse especially among adolescents. Exposure to THC during formative years produces long-term behavioral alterations that share similarities with symptoms of psychiatric and neurodevelopmental disorders. In this study, we have analyzed...

Towards a dynamic processual model of psychedelic microdosing.

International Journal of Drug Policy February 1, 2025 Jason Hughes, Joshua Stuart-Bennett, Michael Dunning et al. 2 citations

Existing research highlights an increase in psychedelic microdosing, particularly for therapeutic purposes and as a means for self-enhancement. However, we know little about the different routes into and out of microdosing, particularly by those who do not consume other illicit substances, and of the processes involved in the development, maintenance, and cessation of practices. Drawing upon a...

ASSOCIATIONS BETWEEN ESCITALOPRAM AND PSILOCYBIN THERAPY AND BRAIN RESTING-STATE FUNCTIONAL CONNECTIVITY IN MAJOR DEPRESSIVE DISORDER

The International Journal of Neuropsychopharmacology February 1, 2025 Rebecca Harding, Natalie Ertl, Rayyan Zafar

Abstract Major Depressive Disorder (MDD) is a highly prevalent mental health condition characterized by symptoms including anhedonia, which is defined as diminished pleasure, and impulsivity, which has been linked to increased substance abuse, self-harm and suicidal tendencies. Both anhedonia and impulsivity have been contributed to alterations in reward system function, with the striatum being...

Emergency Department Visits Involving Hallucinogen Use and Risk of Schizophrenia Spectrum Disorder.

JAMA Psychiatry February 1, 2025 Daniel T. Myran, Michael Pugliese, Jennifer Xiao et al. 23 citations

Interest in and use of hallucinogens has been increasing rapidly. While a frequently raised concern is that hallucinogens may be associated with an increased risk of psychosis, there are limited data on this association. To examine whether individuals with an emergency department (ED) visit involving hallucinogen use have an increased risk of developing a schizophrenia spectrum disorder (SSD)....

Cardiovascular effects and safety of classic psychedelics.

Nature cardiovascular research February 1, 2025 Acile Nahlawi, Leon M Ptaszek, Jeremy N Ruskin 15 citations

Psychedelics, used for millennia in spiritual and healing practices, have emerged as promising treatments for mental health conditions including depression, post-traumatic stress disorder (PTSD), substance use disorders and anxiety. Despite the therapeutic potential of psychedelics and their increasing use in both medical and nonmedical settings, there is a paucity of data on their...

Consciousness in non-REM-parasomnia episodes.

Journal of Sleep Research February 1, 2025 Francesca Siclari 11 citations

Sleepwalking and related parasomnias are thought to result from incomplete awakenings out of non-rapid eye movement (non-REM) sleep. Non-REM parasomnia behaviours have been described as unconscious and automatic, or related to vivid, dream-like conscious experiences. Similarly, some observations have suggested that patients are unresponsive during episodes, while others that they can interact...

DOI: 10.1111/jsr.14275 (opens in new tab) Full text (opens in new tab) Awakening Behaviour Cognition Confusional arousal +10

Fluoxetine and Ketamine Enhance Extinction Memory and Brain Plasticity by Triggering the p75 Neurotrophin Receptor Proteolytic Pathway.

Biological Psychiatry February 1, 2025 Cassiano Ricardo Alves Faria Diniz, Ana Paula Crestani, Plinio Cabrera Casarotto et al. 15 citations

Diverse antidepressants were recently described to bind to TrkB (tyrosine kinase B) and drive a positive allosteric modulation of endogenous BDNF (brain-derived neurotrophic factor). Although neurotrophins such as BDNF can bind to p75NTR (p75 neurotrophin receptor), their precursors are the high-affinity p75NTR ligands. While part of an unrelated receptor family capable of inducing completely...

What Chemsex does to the brain - neural correlates (ERP) regarding decision making, impulsivity and hypersexuality.

European Archives of Psychiatry and Clinical Neuroscience February 1, 2025 Johanna Schwarz, Marcus Gertzen, Andrea Rabenstein et al. 14 citations

Chemsex describes the use of specific substances (methamphetamine, GHB/GBL, mephedrone, ketamine) which initiate or enhance sexual experiences and is mainly prevalent among men who have sex with men. Many Chemsex users experience somatic complications (for example sexually transmitted diseases) and sometimes adverse sociological, psychological, and neurological symptoms, such as depression,...

DOI: 10.1007/s00406-024-01856-2 (opens in new tab) Full text (opens in new tab) Chemsex Executive functions Hypersexuality Inhibition +2